A 5-year retrospective longitudinal study on the incidence and the riskfactors of osteonecrosis of the jaws in patients treated with zoledronic acid for bonemetastases from solid tumors

摘要

BackgroundThe aim of this study was to evaluate the incidence and the risk factors of osteonecrosis of the jaw (ONJ) in a group of patients treated with zoledronic acid (ZA) for bone metastases from solid tumors and enrolled in a preventive dental program.